First Time Loading...

Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 0.6036 USD Market Closed
Updated: May 17, 2024

Atara Biotherapeutics Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Atara Biotherapeutics Inc
Retained Earnings Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Atara Biotherapeutics Inc
NASDAQ:ATRA
Retained Earnings
-$2B
CAGR 3-Years
-18%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Retained Earnings
-$1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Retained Earnings
-$27.9B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-15%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Retained Earnings
$10.1B
CAGR 3-Years
128%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Retained Earnings
$28B
CAGR 3-Years
33%
CAGR 5-Years
37%
CAGR 10-Years
N/A

See Also

What is Atara Biotherapeutics Inc's Retained Earnings?
Retained Earnings
-2B USD

Based on the financial report for Mar 31, 2024, Atara Biotherapeutics Inc's Retained Earnings amounts to -2B USD.

What is Atara Biotherapeutics Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-28%

Over the last year, the Retained Earnings growth was -13%. The average annual Retained Earnings growth rates for Atara Biotherapeutics Inc have been -18% over the past three years , -28% over the past five years .